Mesothelioma is a tough cancer to have that is hard to diagnose and understand. Scientists are looking at a protein called mesothelin that could possibly help. This protein might be a clue to the cancer, but we need an easier way to find out more about it. In the new[…]
Mesothelioma
Occupational Vs Environmental Asbestos Exposure and Mesothelioma
Malignant mesothelioma is a cancer caused by asbestos exposure that is very hard to treat. Some people with this cancer live longer than expected. A recent study in a science journal known as Toxics looked at patients with mesothelioma and asbestos-related lung cancer. All of them had been around asbestos[…]
Frequent Collapsed Lung Indicates Mesothelioma
A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old whose recurrent collapsing lung was found to be mesothelioma.[…]
Fungus-Derived Compounds are Showing Promise Against Mesothelioma
Researchers in Japan have identified new chemical compounds derived from a fungus that showed the ability to kill mesothelioma cells in laboratory testing. The findings, published this month in the Journal of Antibiotics, are early-stage but add to a growing body of research exploring natural sources for new mesothelioma treatments.[…]
Immunotherapy to Treat Pleural Effusion
Malignant pleural effusion is a serious condition where cancer cells spread to the lining of the lungs. This leads to fluid buildup in the chest cavity. This fluid accumulation can make breathing difficult and is often a sign of advanced lung cancer. Pleural effusion is a common symptom of malignant[…]
Limited Surgery to Limit Symptoms of Pleural Mesothelioma
A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not possible. This study looks at surgery differently compared to other trials. Rather than focusing first on complete tumor removal, it[…]
PITAC to Treat Mesothelioma
A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers chemotherapy directly to the chest as a pressurized mist. One doctor knows it as “spray paint chemo.” PITAC is minimally[…]
Blood Test Did Not Reduce Late Stage Cancer Diagnoses
A major clinical trial found that a blood test designed to detect cancer early did not reduce the number of late-stage diagnoses. Grail, the manufacturer of the test, reported the findings. The results suggest multi-cancer blood tests may not be as effective as anticipated. The Galleri test looks for fragments[…]
Pleurectomy/Decortication Surgery Has Low Mortality When Patients are Carefully Selected
A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate of early mortality. These findings are in direct contrast to those from the MARS2 trial, which reported P/D surgery carried[…]
Tumor Treating Fields to Treat Mesothelioma and Other Hard to Treat Cancers
Tumor treating fields are an innovative new way to treat cancer. They do not involve surgery or drugs. They are also known as TTFields. TTFields have been approved by the FDA for the use of treating mesothelioma. Mesothelioma is a rare and aggressive cancer that affects the lining of certain[…]
Skip to content